Board Certifications American Board of Nuclear Medicine Licensures New York State Medical license Training Medical School
Internship
Residency Training
Fellowship
|
-
PUBLICATIONS
Selected peer-reviewed publications (in chronological order).
Safaie Semnani E, Nobili F, Di Marco A, Taddei G, Mariani G, Rodriguez G. Longitudinal regional cerebral blood flow studies in patients with Alzheimer’s disease. Eur J Nucl Med 1997;24:980 (abstract).
Villa G, Dottori V, Vinci P, Safaie Semnani E, Rahimi Mansour A, Zoccola R, Mariani G. Radionuclide ventricolography (RNV) and 2D-echocardiography (2D-ECHO) for assessing left ventricular wall motion after mitral valve surgery. J Nucl Cardiol 1999;6(suppl):s107 (abstract).
Villavecchia G, Cabria M, Bertolazzi L, Safaie Semnani E, Pavanello MG, Hanau G, Garaventa A, Debernardi B, Scopinaro G. Immunoscintigraphy with monoclonal antibodies: antiGD2 ch 14.18 in patients with neuroblastoma. In: Proc Convegno Nazionale Progressi della Diagnostica Medico-Nucleare in Oncologia: Non Puro Esercizio Accademico ma Reale Beneficio per Il Paziente. Genova; 1998:51-52.
Nobili F, Coppello F, Buffoni F, Vitali P, Bordoni C, Girtler N, Safaie Semnani E, Mariani G, Rodriguez G. Regional cerebral flow and prognostic evaluation in Alzheimer’s disease. Dement Geriatr Cogn Discord 2001; 12:89-97.
Kassis AI, Kirichian AM, Safaie Semnani E, Adelstein SJ. Therapeutic potential of 5-[125I]iodo-2'-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis. J Nucl Med 2003;44(5, suppl):35P-6P. Presented at the 50th Annual Meeting of the Society of Nuclear Medicine, New Orleans, LA, June 21-25, 2003.
Kassis AI, Kirichian AM, Safaie Semnani E, Adelstein SJ. Therapeutic potential of 5-[125I]iodo-2'-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis. Presented at the Thirteenth L. H. Gray Workshop and the Fifth Auger Symposium, Melbourne, Australia, August 13-16;2003.
Kassis AI, Kirichian AM, Wang K, Adelstein SJ, Safaie Semnani E. Therapeutic potential of 5-[125I]iodo-2'-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis. In: Book of Abstracts of the 12th International Congress of radiation Research, Brisbane, Australia, August 17-22, 2003:267.
Kassis AI, Kirichian AM, Safaie Semnani E, Adelstein SJ. Therapeutic potential of 5-[125I]iodo-2'-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis. Eur J Nucl Med Mol Imaging 2003;30(suppl 2):S188. Presented at the European Association of Nuclear Medicine Annual Congress, Amsterdam, The Netherlands, August 23-27, 2003.
Safaie Semnani E, Wang K, Adelstein SJ, Kassis AI. The potential of 5-[125I/123I]iodo-2’-deoxyuridine in targeting and therapy of metastatic lung cancer. Eur J Nucl Med Mol Imaging 2003;30(suppl 2):S347. Presented at the European Association of Nuclear Medicine Annual Congress, Amsterdam, The Netherlands, August 23-27, 2003.
Elham Safaie Semnani, Ketai Wang, S. James Adelstein, and Amin I. Kassis 5-[123I/125I]Iodo-2'-Deoxyuridine in Metastatic Lung Cancer: Radiopharmaceutical Formulation Affects Targeting J. Nucl. Med. 2005 46: 800-806.
Matthews R, Schuster M, Safaie E, Relan N, Franceschi D. Fluorodeoxyglucose PET-CT Findings Following Bone Marrow Harvesting. World J Nucl Med. 2012 Jan;11(1):19-21.
Franceschi AM, Matthews R, Mankes S, Safaie E, Franceschi D. Four chamber FDG uptake in the heart: an indirect sign of pulmonary embolism. Clin Nucl Med. 2012 Jul;37(7):687-91.